Log In
Print this Print this

Zoenasa Rectal Gel, Zoenasa Rectal Suspension

  Manage Alerts
Collapse Summary General Information
Company Altheus Therapeutics Inc.
DescriptionFixed-dose combination rectal gel of mesalamine (5-aminosalicylic acid) and N-acetylcysteine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat distal ulcerative colitis (UC); Treat pediatric ulcerative colitis (UC)
Regulatory Designation U.S. - Orphan Drug (Treat pediatric ulcerative colitis (UC))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today